DOCSLIB.ORG

Strong Selection During the Last Millennium for African Ancestry In

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Strong selection during the last millennium for African ancestry in the admixed population of Madagascar Denis Pierron, Margit Heiske, Harilanto Razafindrazaka, Veronica Pereda-Loth, Jazmin Sanchez, Omar Alva, Amal Arachiche, Anne Boland, Robert Olaso, Jean-François Deleuze, et al. To cite this version: Denis Pierron, Margit Heiske, Harilanto Razafindrazaka, Veronica Pereda-Loth, Jazmin Sanchez, et al.. Strong selection during the last millennium for African ancestry in the admixed population of Mada- gascar. Nature Communications, Nature Publishing Group, 2018, 9 (1), pp.932. 10.1038/s41467-018- 03342-5. hal-02112693 HAL Id: hal-02112693 https://hal.archives-ouvertes.fr/hal-02112693 Submitted on 9 Jan 2020 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Distributed under a Creative Commons Attribution| 4.0 International License ARTICLE DOI: 10.1038/s41467-018-03342-5 OPEN Strong selection during the last millennium for African ancestry in the admixed population of Madagascar Denis Pierron1, Margit Heiske1, Harilanto Razafindrazaka2,1, Veronica Pereda-loth1, Jazmin Sanchez1, Omar Alva1, Amal Arachiche1, Anne Boland3, Robert Olaso3, Jean-Francois Deleuze3, Francois-Xavier Ricaut1, Jean-Aimé Rakotoarisoa4, Chantal Radimilahy4, Mark Stoneking5 & Thierry Letellier1 1234567890():,; While admixed populations offer a unique opportunity to detect selection, the admixture in most of the studied populations occurred too recently to produce conclusive signals. By contrast, Malagasy populations originate from admixture between Asian and African popu- lations that occurred ~27 generations ago, providing power to detect selection. We analyze local ancestry across the genomes of 700 Malagasy and identify a strong signal of recent positive selection, with an estimated selection coefficient >0.2. The selection is for African ancestry and affects 25% of chromosome 1, including the Duffy blood group gene. The null allele at this gene provides resistance to Plasmodium vivax malaria, and previous studies have suggested positive selection for this allele in the Malagasy population. This selection event also influences numerous other genes implicated in immunity, cardiovascular diseases, and asthma and decreases the Asian ancestry genome-wide by 10%, illustrating the role played by selection in recent human history. 1 Laboratoire d’Anthropologie Moleculairé et Imagerie de Synthese,̀ UMR 5288 CNRS, Universitéde Toulouse, 31073 Toulouse, France. 2 Aix Marseille Univ., CNRS, EFS, ADES, Marseille, France. 3 Commissariat à l’Energie Atomique, Institut Génomique, Centre National de Génotypage, 91000 Evry, France. 4 Institut de Civilisations/Musée d’Art et d’Archeologie,́ Université d’Antananarivo, 101 Antananarivo, Madagascar. 5 Department of Evolutionary Genetics, Max Planck Institute for Evolutionary Anthropology, Deutscher Platz 6, D-04103 Leipzig, Germany. Correspondence and requests for materials should be addressed to D.P. (email: [email protected]) NATURE COMMUNICATIONS | (2018) 9:932 | DOI: 10.1038/s41467-018-03342-5 | www.nature.com/naturecommunications 1 ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-03342-5 peaking an Austronesian language and living <400 km from As the admixture in Madagascar occurred ~27 generations the African coast, the origins and history of the Malagasy ago4 and involves populations that diverged at least 50 000 years S 14 populations have long been a mystery. Recently, combined ago , the admixture approach should be informative, as ancestry advances in archeology, genetics, and linguistics, along with can be confidently assigned and there has been ample time for extensive sampling across Malagasy populations, provide a better selection to generate a detectable signal. Indeed, signals of positive – understanding of the settlement history1 3. Indeed, Malagasy selection have been detected in the Malagasy populations2, 15.In populations originate from an admixture between populations particular Hodgson et al.15 showed that under neutrality the high with Austronesian and Bantu genetic backgrounds that occurred frequency of the African Duffy null allele in the Malagasy ~27 generations ago4. Linguistic and genetic evidence converge population16 is incompatible with the admixture level measured on a model of Bantu populations migrating across the Mozam- in Madagascar; this allele is associated with protection against bique channel from the east coast of Africa, while the Aus- Plasmodium vivax malaria and is fixed (or nearly so) in Africa but tronesian population came 7000 km across the Indian Ocean essentially absent outside Africa17. This study analyzed variation from south Borneo3. at a single single-nucleotide polymorphism (SNP) in two Mala- The meetings of these two populations led to both cultural and gasy populations15, here, to further investigate this as well as genetic mixture, generating a patchwork of cultural and genetic other potential signals of recent positive selection, we performed a traits across Madagascar. For example, while the language is genome-wide analysis of local ancestry across the genomes of 700 mostly Austronesian, the musical instruments are mostly from Malagasy based on a sampling from 257 villages from all across Africa5, and Austronesian genetic ancestry is higher in the central Madagascar4.Wefind that the Malagasy genome has been shaped highlands than elsewhere4. The cultural and genomic landscape by a selection event, probably corresponding to selection for the of Madagascar mostly reflects historic events of contact between Duffy null allele, that is exceptional in terms of strength (s > 0.2) groups followed by random fluctuations. However, some cultural and overall impact (~25% of the chromosome is in the selected aspects, such as farming, might reflect cultural adaptation to region). Moreover, this selection has been ongoing over the last environmental constraints, as the adoption of crops and farming millennium, showing that recent selection does influence human practices varied according to environmental circumstances6. Here populations. we test the hypothesis that in addition to culture adaptation, genetic adaptation has also played a role in the history of Madagascar, by examining the distribution of Austronesian- Results related and Bantu-related genetic ancestry across Malagasy Local ancestry estimation. To look for signals of recent positive genomes. selection, we used the mixed ancestry of Malagasy genomes and In the absence of selection, the ancestry associated with each searched for genomic regions with unusually high or low levels of parental group of an admixed population is expected to be dis- African or Asian ancestry. To measure the Asian and African tributed more or less evenly across the genome; significant contribution across the Malagasy genome, we used the Efficient departures from this expected random distribution are thus a Local Ancestry Inference (ELAI) algorithm to perform local potential signal of selection. This approach has been used to ancestry inference on 1.9 million SNPs genotyped in 700 indi- demonstrate the importance of “adaptive introgression” of genes 4 – viduals sampled from 257 villages across Madagascar . The between modern populations7 10 or even between archaic – average Asian ancestry across individuals was 38.47 ± 3.0% per humans and modern populations11 13. However, detecting position across the genome, in agreement with previous admixture-related selection is problematic in modern populations studies2, 4, 15. where the admixture occurred only a few generations ago, as The distribution of the ancestry inference across each position there may not have been enough time for selection to generate a in the genome (Fig. 1) revealed a highly significant decrease in detectable signal in the distribution of ancestry across the gen- Asian ancestry (and corresponding increase in African ancestry) ome. For example, there is ongoing debate concerning results on chromosome 1 near the locus 1q23. The lowest Asian ancestry suggesting positive selection for African alleles at some loci in the in this region is 8.7%, corresponding to a deviation of 9.9 standard – − Americas7 9. deviations (SDs) from the mean and a p-value < 10 16 (Grubbs 12345678910111213141516171819202122 50 40 30 % of Asian ancestry 20 10 Chromosomic physical positions Fig. 1 Average Asian ancestry estimated using ELAI, across the 700 Malagasy individuals, for each position of each chromosome. In this analysis the African and Asian populations from the 1000 Genomes Project22 were used as proxies for the African and Asian ancestry in the Malagasy; the results from other reference populations are provided in Supplementary Figure, and using other approaches and reference populations in Supplementary Figures 2 and 3. Black lines represent a deviation of 3 SD from the mean and blue lines represent a deviation of 6 SD from the mean 2 NATURE COMMUNICATIONS | (2018) 9:932 | DOI: 10.1038/s41467-018-03342-5 | www.nature.com/naturecommunications NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-03342-5 ARTICLE
Recommended publications
  • Genetic Variation Across the Human Olfactory Receptor Repertoire Alters Odor Perception

    Genetic Variation Across the Human Olfactory Receptor Repertoire Alters Odor Perception

    bioRxiv preprint doi: https://doi.org/10.1101/212431; this version posted November 1, 2017. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. Genetic variation across the human olfactory receptor repertoire alters odor perception Casey Trimmer1,*, Andreas Keller2, Nicolle R. Murphy1, Lindsey L. Snyder1, Jason R. Willer3, Maira Nagai4,5, Nicholas Katsanis3, Leslie B. Vosshall2,6,7, Hiroaki Matsunami4,8, and Joel D. Mainland1,9 1Monell Chemical Senses Center, Philadelphia, Pennsylvania, USA 2Laboratory of Neurogenetics and Behavior, The Rockefeller University, New York, New York, USA 3Center for Human Disease Modeling, Duke University Medical Center, Durham, North Carolina, USA 4Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, North Carolina, USA 5Department of Biochemistry, University of Sao Paulo, Sao Paulo, Brazil 6Howard Hughes Medical Institute, New York, New York, USA 7Kavli Neural Systems Institute, New York, New York, USA 8Department of Neurobiology and Duke Institute for Brain Sciences, Duke University Medical Center, Durham, North Carolina, USA 9Department of Neuroscience, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA *[email protected] ABSTRACT The human olfactory receptor repertoire is characterized by an abundance of genetic variation that affects receptor response, but the perceptual effects of this variation are unclear. To address this issue, we sequenced the OR repertoire in 332 individuals and examined the relationship between genetic variation and 276 olfactory phenotypes, including the perceived intensity and pleasantness of 68 odorants at two concentrations, detection thresholds of three odorants, and general olfactory acuity.
  • Bahl Et Al Revisedmanuscript.Pdf

    Bahl Et Al Revisedmanuscript.Pdf

    This is an electronic reprint of the original article. This reprint may differ from the original in pagination and typographic detail. Author(s): Bahl, Aileen; Pöllänen, Eija; Ismail, Khadeeja; Sipilä, Sarianna; Mikkola, Tuija; Berglund, Eva; Lindqvist, Carl Mårten; Syvänen, Ann-Christine; Rantanen, Taina; Kaprio, Jaakko; Kovanen, Vuokko; Ollikainen, Miina Title: Hormone Replacement Therapy Associated White Blood Cell DNA Methylation and Gene Expression are Associated With Within-Pair Differences of Body Adiposity and Bone Mass Year: 2015 Version: Please cite the original version: Bahl, A., Pöllänen, E., Ismail, K., Sipilä, S., Mikkola, T., Berglund, E., . Ollikainen, M. (2015). Hormone Replacement Therapy Associated White Blood Cell DNA Methylation and Gene Expression are Associated With Within-Pair Differences of Body Adiposity and Bone Mass. Twin Research and Human Genetics, 18 (6), 647-661. doi:10.1017/thg.2015.82 All material supplied via JYX is protected by copyright and other intellectual property rights, and duplication or sale of all or part of any of the repository collections is not permitted, except that material may be duplicated by you for your research use or educational purposes in electronic or print form. You must obtain permission for any other use. Electronic or print copies may not be offered, whether for sale or otherwise to anyone who is not an authorised user. Hormone replacement therapy associated white blood cell DNA methylation and gene expression are associated with within-pair differences of body adiposity
  • Whole Exome Sequencing in Families at High Risk for Hodgkin Lymphoma: Identification of a Predisposing Mutation in the KDR Gene

    Whole Exome Sequencing in Families at High Risk for Hodgkin Lymphoma: Identification of a Predisposing Mutation in the KDR Gene

    Hodgkin Lymphoma SUPPLEMENTARY APPENDIX Whole exome sequencing in families at high risk for Hodgkin lymphoma: identification of a predisposing mutation in the KDR gene Melissa Rotunno, 1 Mary L. McMaster, 1 Joseph Boland, 2 Sara Bass, 2 Xijun Zhang, 2 Laurie Burdett, 2 Belynda Hicks, 2 Sarangan Ravichandran, 3 Brian T. Luke, 3 Meredith Yeager, 2 Laura Fontaine, 4 Paula L. Hyland, 1 Alisa M. Goldstein, 1 NCI DCEG Cancer Sequencing Working Group, NCI DCEG Cancer Genomics Research Laboratory, Stephen J. Chanock, 5 Neil E. Caporaso, 1 Margaret A. Tucker, 6 and Lynn R. Goldin 1 1Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD; 2Cancer Genomics Research Laboratory, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD; 3Ad - vanced Biomedical Computing Center, Leidos Biomedical Research Inc.; Frederick National Laboratory for Cancer Research, Frederick, MD; 4Westat, Inc., Rockville MD; 5Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD; and 6Human Genetics Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD, USA ©2016 Ferrata Storti Foundation. This is an open-access paper. doi:10.3324/haematol.2015.135475 Received: August 19, 2015. Accepted: January 7, 2016. Pre-published: June 13, 2016. Correspondence: [email protected] Supplemental Author Information: NCI DCEG Cancer Sequencing Working Group: Mark H. Greene, Allan Hildesheim, Nan Hu, Maria Theresa Landi, Jennifer Loud, Phuong Mai, Lisa Mirabello, Lindsay Morton, Dilys Parry, Anand Pathak, Douglas R. Stewart, Philip R. Taylor, Geoffrey S. Tobias, Xiaohong R. Yang, Guoqin Yu NCI DCEG Cancer Genomics Research Laboratory: Salma Chowdhury, Michael Cullen, Casey Dagnall, Herbert Higson, Amy A.
  • Sequencing of 50 Human Exomes Reveals Adaptation to High Altitude

    Sequencing of 50 Human Exomes Reveals Adaptation to High Altitude

    REPORTS Digestive and Kidney Diseases) and The University of Omnibus, with accession code GSE21661. These data, as Figs. S1 to S6 Luxembourg–Institute for Systems Biology Program to well as phenotype data, are also available on our Tables S1 to S12 C.D.H. T.S.S. was supported by NIH Genetics Training laboratory Web site, http://jorde-lab.genetics.utah. References Grant T32. All studies have been performed with edu. Please contact R.L.G. for access to DNA samples. informed consent approved by the Institutional Board of 10 March 2010; accepted 6 May 2010 Qinghai Medical College of Qinghai University in Supporting Online Material Published online 13 May 2010; Xining, Qinghai Province, People’s Republic of China. All www.sciencemag.org/cgi/content/full/science.1189406/DC1 10.1126/science.1189406 SNP genoptypes are deposited in Gene Expression Materials and Methods Include this information when citing this paper. also estimated single-nucleotide polymorphism Sequencing of 50 Human Exomes (SNP) probabilities and population allele frequen- cies for each site. A total of 151,825 SNPs were Reveals Adaptation to High Altitude inferred to have >50% probability of being var- iable within the Tibetan sample, and 101,668 had Xin Yi,1,2* Yu Liang,1,2* Emilia Huerta-Sanchez,3* Xin Jin,1,4* Zha Xi Ping Cuo,2,5* John E. Pool,3,6* >99% SNP probability (table S2). Sanger se- Xun Xu,1 Hui Jiang,1 Nicolas Vinckenbosch,3 Thorfinn Sand Korneliussen,7 Hancheng Zheng,1,4 quencing validated 53 of 56 SNPs that had at least Tao Liu,1 Weiming He,1,8 Kui Li,2,5 Ruibang Luo,1,4 Xifang Nie,1 Honglong Wu,1,9 Meiru Zhao,1 95% SNP probability and minor allele frequencies Hongzhi Cao,1,9 Jing Zou,1 Ying Shan,1,4 Shuzheng Li,1 Qi Yang,1 Asan,1,2 Peixiang Ni,1 Geng Tian,1,2 between 3% and 50%.
  • Supporting Information Supplementary Methods Patients for Whole Genome Sequencing and Validation Cohort. Heparinized Bone Marrow

    Supporting Information Supplementary Methods Patients for Whole Genome Sequencing and Validation Cohort. Heparinized Bone Marrow

    Supporting Information Supplementary Methods Patients for whole genome sequencing and validation cohort. Heparinized bone marrow samples were obtained from 8 RAEB patients with informed consent for WGS according to the ethics review board of Shanghai Institute of Hematology. Briefly, these 8 patients were 4 RAEB-1, 4 RAEB-2, 5 males, 3 females, 1 with complex karyotype, 1 with +8, 5 with normal karyotype, and classified as intermediate to very high risk level. 6 patients died 4-23 months after diagnosis of infection, hemorrhage, cerebral infarction or evolution to AML (complete information see Table S1). The validation cohort consisted of 188 various subtypes of MDS patients diagnosed and treated in Shanghai Ruijin Hospital and Shanghai No.6 People’s Hospital. All patients provided written informed consent. Bone marrow and paired buccal samples were obtained after informed consent. DNA sample preparation. Mononuclear cells (MNC) were separated by density gradient centrifugation using Ficoll in 8 RAEB patients and 188 MDS patients from validation cohort. Subsequently, CD34+ cells were isolated by magnetic cell separation (Miltenyi Biotech, Bergisch Gladbach, Germany) to reach a purity of 89-97.7% (average: 93.1%) in 8 RAEB patients. Flow through CD34- cells were also collected for analysis. Skin biopsy was obtained for analysis of normal genome and extracted by DNeasy Blood & Tissue Kit (Qiagen). Genomic DNA of CD34+ cells were isolated by QuickGene DNA whole blood kit L (FUJIFILM, Life Science). Genomic DNA of MNC from validation set was extracted by Wizard® Genomic DNA Purification Kit (Promega). DNA library preparation. Genomic DNA was sheared by sonication 1 and adaptors were ligated to the resulting fragments.
  • Incorporating Genetic Networks Into Case-Control Association Studies with High-Dimensional DNA Methylation Data Kipoong Kim and Hokeun Sun*

    Incorporating Genetic Networks Into Case-Control Association Studies with High-Dimensional DNA Methylation Data Kipoong Kim and Hokeun Sun*

    Kim and Sun BMC Bioinformatics (2019) 20:510 https://doi.org/10.1186/s12859-019-3040-x METHODOLOGY ARTICLE Open Access Incorporating genetic networks into case-control association studies with high-dimensional DNA methylation data Kipoong Kim and Hokeun Sun* Abstract Background: In human genetic association studies with high-dimensional gene expression data, it has been well known that statistical selection methods utilizing prior biological network knowledge such as genetic pathways and signaling pathways can outperform other methods that ignore genetic network structures in terms of true positive selection. In recent epigenetic research on case-control association studies, relatively many statistical methods have been proposed to identify cancer-related CpG sites and their corresponding genes from high-dimensional DNA methylation array data. However, most of existing methods are not designed to utilize genetic network information although methylation levels between linked genes in the genetic networks tend to be highly correlated with each other. Results: We propose new approach that combines data dimension reduction techniques with network-based regularization to identify outcome-related genes for analysis of high-dimensional DNA methylation data. In simulation studies, we demonstrated that the proposed approach overwhelms other statistical methods that do not utilize genetic network information in terms of true positive selection. We also applied it to the 450K DNA methylation array data of the four breast invasive carcinoma cancer subtypes from The Cancer Genome Atlas (TCGA) project. Conclusions: The proposed variable selection approach can utilize prior biological network information for analysis of high-dimensional DNA methylation array data. It first captures gene level signals from multiple CpG sites using data a dimension reduction technique and then performs network-based regularization based on biological network graph information.
  • 1 Genome-Wide Comparisons of Variation in Linkage Disequilibrium

    1 Genome-Wide Comparisons of Variation in Linkage Disequilibrium

    Downloaded from genome.cshlp.org on September 30, 2021 - Published by Cold Spring Harbor Laboratory Press Genome-wide comparisons of variation in linkage disequilibrium Yik Y. Teo1,*, Andrew E. Fry1, Kanishka Bhattacharya1, Kerrin S. Small1, Dominic P. Kwiatkowski1,2, Taane G. Clark1,2 1 Wellcome Trust Centre for Human Genetics, University of Oxford, United Kingdom 2 Wellcome Trust Sanger Institute, Hinxton, United Kingdom Running title: Genome-wide comparisons of LD Keywords: linkage disequilibrium, imputation, positive selection, meta-analysis, genome-wide association study * Corresponding author: Wellcome Trust Centre for Human Genetics, Roosevelt Drive, Oxford OX3 7BN, United Kingdom. Email: [email protected], phone: +44 1865 287712, fax: +44 1865 287 501. ABSTRACT Current genome-wide surveys of common diseases and complex traits fundamentally aim to detect indirect associations where the SNPs carrying the association signals are not biologically active but are in linkage disequilibrium (LD) with some unknown functional polymorphisms. Reproducing any novel discoveries from these genome-wide scans in independent studies is now a prerequisite for the putative findings to be accepted. Significant differences in patterns of LD between populations can affect the portability of phenotypic associations when the replication effort or meta-analyses are attempted in populations that are distinct from the original population which the genome-wide study is performed in. Here we introduce a novel method for genome-wide analyses of LD variations between populations that allow the identification of candidate regions with different patterns of LD. The evidence of LD variation provided by the introduced method correlated with the degree of differences in the frequencies of the most common haplotype across the populations.
  • Identification of Candidate Biomarkers and Pathways Associated with Type 1 Diabetes Mellitus Using Bioinformatics Analysis

    Identification of Candidate Biomarkers and Pathways Associated with Type 1 Diabetes Mellitus Using Bioinformatics Analysis

    bioRxiv preprint doi: https://doi.org/10.1101/2021.06.08.447531; this version posted June 9, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Identification of candidate biomarkers and pathways associated with type 1 diabetes mellitus using bioinformatics analysis Basavaraj Vastrad1, Chanabasayya Vastrad*2 1. Department of Biochemistry, Basaveshwar College of Pharmacy, Gadag, Karnataka 582103, India. 2. Biostatistics and Bioinformatics, Chanabasava Nilaya, Bharthinagar, Dharwad 580001, Karnataka, India. * Chanabasayya Vastrad [email protected] Ph: +919480073398 Chanabasava Nilaya, Bharthinagar, Dharwad 580001 , Karanataka, India bioRxiv preprint doi: https://doi.org/10.1101/2021.06.08.447531; this version posted June 9, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Abstract Type 1 diabetes mellitus (T1DM) is a metabolic disorder for which the underlying molecular mechanisms remain largely unclear. This investigation aimed to elucidate essential candidate genes and pathways in T1DM by integrated bioinformatics analysis. In this study, differentially expressed genes (DEGs) were analyzed using DESeq2 of R package from GSE162689 of the Gene Expression Omnibus (GEO). Gene ontology (GO) enrichment analysis, REACTOME pathway enrichment analysis, and construction and analysis of protein-protein interaction (PPI) network, modules, miRNA-hub gene regulatory network and TF-hub gene regulatory network, and validation of hub genes were then performed. A total of 952 DEGs (477 up regulated and 475 down regulated genes) were identified in T1DM. GO and REACTOME enrichment result results showed that DEGs mainly enriched in multicellular organism development, detection of stimulus, diseases of signal transduction by growth factor receptors and second messengers, and olfactory signaling pathway.
  • WO 2019/068007 Al Figure 2

    WO 2019/068007 Al Figure 2

    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization I International Bureau (10) International Publication Number (43) International Publication Date WO 2019/068007 Al 04 April 2019 (04.04.2019) W 1P O PCT (51) International Patent Classification: (72) Inventors; and C12N 15/10 (2006.01) C07K 16/28 (2006.01) (71) Applicants: GROSS, Gideon [EVIL]; IE-1-5 Address C12N 5/10 (2006.0 1) C12Q 1/6809 (20 18.0 1) M.P. Korazim, 1292200 Moshav Almagor (IL). GIBSON, C07K 14/705 (2006.01) A61P 35/00 (2006.01) Will [US/US]; c/o ImmPACT-Bio Ltd., 2 Ilian Ramon St., C07K 14/725 (2006.01) P.O. Box 4044, 7403635 Ness Ziona (TL). DAHARY, Dvir [EilL]; c/o ImmPACT-Bio Ltd., 2 Ilian Ramon St., P.O. (21) International Application Number: Box 4044, 7403635 Ness Ziona (IL). BEIMAN, Merav PCT/US2018/053583 [EilL]; c/o ImmPACT-Bio Ltd., 2 Ilian Ramon St., P.O. (22) International Filing Date: Box 4044, 7403635 Ness Ziona (E.). 28 September 2018 (28.09.2018) (74) Agent: MACDOUGALL, Christina, A. et al; Morgan, (25) Filing Language: English Lewis & Bockius LLP, One Market, Spear Tower, SanFran- cisco, CA 94105 (US). (26) Publication Language: English (81) Designated States (unless otherwise indicated, for every (30) Priority Data: kind of national protection available): AE, AG, AL, AM, 62/564,454 28 September 2017 (28.09.2017) US AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, 62/649,429 28 March 2018 (28.03.2018) US CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, (71) Applicant: IMMP ACT-BIO LTD.
  • The Role of MDM2 and CDK4 in Well Differentiated Liposarcoma Dr

    The Role of MDM2 and CDK4 in Well Differentiated Liposarcoma Dr

    The role of MDM2 and CDK4 in well differentiated liposarcoma Dr Rachel Katherine Conyers Submitted in total fulfillment of the requirements of the degree of Doctor of Philosophy April 2015 Department of Pathology The University of Melbourne i Abstract Transformation of normal cells to cancer cells is tightly linked to fundamental changes in cell cycle regulation. In addition, oncogenes can aberrantly enhance cell proliferation. Two genes; Cyclin dependent kinase-4 (CDK4) and Murine double minute 2 (MDM2) are amplified and overexpressed in over 90% of well differentiated liposarcomas. Their role in cell cycle control, and regulation of tumour suppressor p53 respectively, strongly suggesting that deregulation of these genes confers some selective advantage to this tumour. To elucidate the role of these genes in the development and progression of liposarcoma I have used transgenic mouse models and in vitro assays. Given the recent development of novel CDK4 inhibitors, I have tested several CDK4 inhibitors (sc-203873, sc-203874, NPCD, PD 0332991) on liposarcoma cell lines (449B, T1000, 778, GOT3) to determine sensitivity to inhibition, cell cycle arrest and downstream effects of inhibition. PD033991 was found to be the most selective and sensitive CDK4 inhibitor and, as such, was used in a siRNA screen of the genome to identify co-modifiers of CDK4 inhibition. A total of 13 genes were identified that produced a resistance phenotype in the context of CDK4 inhibition. Two of these genes; Arrestin, beta 2 (ARRB2) and Dysferlin (DYSF) demonstrated a reproducible resistance phenotype in a series of functional validation studies. ii Declaration This is to certify that: i the thesis comprises only my original work towards the PhD except where indicated in the Preface, ii due acknowledgement has been made in the text to all other material used, iii the thesis is fewer than 100 000 words in length, exclusive of tables, maps, bibliographies and appendices.
  • Sean Raspet – Molecules

    Sean Raspet – Molecules

    1. Commercial name: Fructaplex© IUPAC Name: 2-(3,3-dimethylcyclohexyl)-2,5,5-trimethyl-1,3-dioxane SMILES: CC1(C)CCCC(C1)C2(C)OCC(C)(C)CO2 Molecular weight: 240.39 g/mol Volume (cubic Angstroems): 258.88 Atoms number (non-hydrogen): 17 miLogP: 4.43 Structure: Biological Properties: Predicted Druglikenessi: GPCR ligand -0.23 Ion channel modulator -0.03 Kinase inhibitor -0.6 Nuclear receptor ligand 0.15 Protease inhibitor -0.28 Enzyme inhibitor 0.15 Commercial name: Fructaplex© IUPAC Name: 2-(3,3-dimethylcyclohexyl)-2,5,5-trimethyl-1,3-dioxane SMILES: CC1(C)CCCC(C1)C2(C)OCC(C)(C)CO2 Predicted Olfactory Receptor Activityii: OR2L13 83.715% OR1G1 82.761% OR10J5 80.569% OR2W1 78.180% OR7A2 77.696% 2. Commercial name: Sylvoxime© IUPAC Name: N-[4-(1-ethoxyethenyl)-3,3,5,5tetramethylcyclohexylidene]hydroxylamine SMILES: CCOC(=C)C1C(C)(C)CC(CC1(C)C)=NO Molecular weight: 239.36 Volume (cubic Angstroems): 252.83 Atoms number (non-hydrogen): 17 miLogP: 4.33 Structure: Biological Properties: Predicted Druglikeness: GPCR ligand -0.6 Ion channel modulator -0.41 Kinase inhibitor -0.93 Nuclear receptor ligand -0.17 Protease inhibitor -0.39 Enzyme inhibitor 0.01 Commercial name: Sylvoxime© IUPAC Name: N-[4-(1-ethoxyethenyl)-3,3,5,5tetramethylcyclohexylidene]hydroxylamine SMILES: CCOC(=C)C1C(C)(C)CC(CC1(C)C)=NO Predicted Olfactory Receptor Activity: OR52D1 71.900% OR1G1 70.394% 0R52I2 70.392% OR52I1 70.390% OR2Y1 70.378% 3. Commercial name: Hyperflor© IUPAC Name: 2-benzyl-1,3-dioxan-5-one SMILES: O=C1COC(CC2=CC=CC=C2)OC1 Molecular weight: 192.21 g/mol Volume
  • Prognostic Classifier Based on Genome-Wide DNA Methylation Profiling in Well-Differentiated Thyroid Tumors

    Prognostic Classifier Based on Genome-Wide DNA Methylation Profiling in Well-Differentiated Thyroid Tumors

    CLINICAL RESEARCH ARTICLE Downloaded from https://academic.oup.com/jcem/article-abstract/102/11/4089/4082866 by Universidade Estadual Paulista J�lio de Mesquita Filho user on 06 May 2019 Prognostic Classifier Based on Genome-Wide DNA Methylation Profiling in Well-Differentiated Thyroid Tumors Mariana Bisarro dos Reis,1,2* Mateus Camargo Barros-Filho,1* F´abio Albuquerque Marchi,1 Caroline Moraes Beltrami,1 Hellen Kuasne,1 Clovis ´ Antonioˆ Lopes Pinto,3 Srikant Ambatipudi,4,5 Zdenko Herceg,4 Luiz Paulo Kowalski,6 and Silvia Regina Rogatto2,7 1International Research Center, CIPE, A.C. Camargo Cancer Center and National Institute of Science and Technology in Oncogenomics, S~ao Paulo 01509-010, SP, Brazil; 2Department of Urology, Faculty of Medicine, UNESP, S~ao Paulo State University, Botucatu 18618-970, SP, Brazil; 3Department of Pathology, A.C. Camargo Cancer Center, S~ao Paulo 01509-010, SP, Brazil; 4Epigenetics Group; International Agency for Research on Cancer (IARC), Lyon 69372, France; 5MRC Integrative Epidemiology Unit, University of Bristol, Bristol BS8 1TH, United Kingdom; 6Department of Head and Neck Surgery and Otorhinolaryngology, A.C. Camargo Cancer Center, S~ao Paulo 01509-010, SP, Brazil; and 7Department of Clinical Genetics, Vejle Hospital and Institute of Regional Health Research, University of Southern Denmark, Vejle, 7100, Denmark Context: Even though the majority of well-differentiated thyroid carcinoma (WDTC) is indolent, a number of cases display an aggressive behavior. Cumulative evidence suggests that the deregulation of DNA methylation has the potential to point out molecular markers associated with worse prognosis. Objective: To identify a prognostic epigenetic signature in thyroid cancer.